AM06 Significantly Improves Liver NAS Scores
After 18 weeks of treatment, both the low-dose and inactivated AM06 groups significantly reduced liver NAS scores in mice, demonstrating that AM06 and its inactivated form can effectively improve liver pathology in late-stage treatment models.
AM06 significantly improves lipid profiles and insulin resistance (HOMA-IR)
